Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 1/20 | 0.43 |
| ▸ | TOP2A | P11388 | 1/20 | 0.43 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.43 |
| ▸ | SNCA | P37840 | 4/20 | 0.43 |
| ▸ | ERN1 | O75460 | 10/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.37 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.37 |
| ▸ | NQO2 | P16083 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22465977 | 0.83 | TOP1 (0.41) | TOP1TOP2ATOP2BSNCAERN1 | |
| SCHEMBL29378214 | 0.83 | TOP1 (0.41) | TOP1TOP2ATOP2BSNCAERN1 | |
| SCHEMBL29374896 | 0.81 | NPC1 (0.54) | TOP1TOP2ATOP2BSNCA | |
| SCHEMBL22466034 | 0.81 | NPC1 (0.54) | TOP1TOP2ATOP2BSNCA | |
| SCHEMBL22466044 | 0.80 | ERN1 (0.50) | TOP1TOP2ATOP2BSNCAERN1 | |
| SCHEMBL29381898 | 0.80 | ERN1 (0.50) | TOP1TOP2ATOP2BSNCAERN1 | |
| SCHEMBL22485072 | 0.76 | KCNQ3 (0.45) | KCNQ3KCNQ2 | |
| SCHEMBL22466162 | 0.75 | RAB9A (0.44) | TOP1TOP2ATOP2BSNCAERN1 | |
| SCHEMBL22466035 | 0.74 | RAB9A (0.57) | KCNQ3KCNQ2 | |
| SCHEMBL29377773 | 0.74 | RAB9A (0.57) | KCNQ3KCNQ2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020198368-A1 | COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING | NEUROPORE THERAPIES, INC. (US) | 2020-10-01 | — | — | WO | disclosed |